Wednesday, February 24, 2010

Aggression and Omega 3 supplements

A very recent article in the journal of Aggressive Behaviour (Volume 36, Issue 2, Pages 117-126), yes there is such a journal, found that supplements which included omega-3s, vitamins and minerals were associated with a 34 per cent reduction in violent incidents, while the placebo group (received no supplements) had a 14 per cent increase in the number of reported incidents. This is following on from a study of young violent offenders reported in the British Journal of Psychiatry, in 2002 which found a 39% reduction in violent offences when they supplemented with a similar mix of nutrients. This is understandable if you look into a bit of the brain chemistry and the role of fatty acids and nutrients involved in healthy brain function.

Imagine we could reduce the violent behaviour out there in the community by getting people to eat well and supplement. Next time someone gets angry at you go tell them to take some supplements. The only real difference is that these people in the study are in prison. I know many kids who probably eat a lot worse than those in prison.

Monday, February 15, 2010

Breast cancer Anti depressants and Fish oils

While growing research shows the SSRI antidepressants (the ones most people take) don’t work beyond that of a placebo another blow occurred to these drugs when a recent (this week) article in the British Medical Journal found the depression drugs paroxetine and probably fluoxetine led to a reduction in the effectiveness of tamoxifen, and an breast cancer mortality for those being treated. The researchers estimated that for every 20 women with treatment overlaps of 41%, and one extra death for every 7 women overlapping 100%.

Interestingly these drugs have been around and used together for decades so how many woman have died in the interim?

By contrast another article this week in the British Journal of Cancer found that Supplements of the omega-3 fatty acid docosahexaenoic acid (DHA) which can also be used to reduce depression and many other chronic illnesses, improve outcomes for breast cancer patients undergoing chemotherapy with no adverse side effects. The study was of advanced cancers with spreading (metastasis) and overall survival of women was 22 months and went to 34 months in women with the highest DHA levels in their blood.
There is a large amount of research on the benefits of using supplements alongside allopathic cancer treatments despite what the chemo therapists say. The research is there that supplementing helps the treatment and minimises the side effects.

Wednesday, February 10, 2010

Big studies are the first hint that statin drugs don’t work

The first hint that the statin drugs don’t save lives is the size of the studies. If the drugs were so effective and the “miracle drugs” they are made out to be, researchers could treat 100 or maybe even 20 patients and see a benefit. Yet these meta-analyses use thousands of people—10,000, 50,000 or even 90,000—treated to show a benefit. If it is so good why do they need such large samples?

As readers of the scientific journals we should not get confused between statistical significance and clinical significance. “Statistically significant” means that the outcome was likely (95% chance) a result of the treatment whether it was 100% effective or less than 0.1% effective. That is, if you treat 1,000 people to save one life (0.1%) it may be statistically significant but it is not clinically significant. Clinical significance is 20% to 30% or more. The best studies on statins by the drug companies report statistical significance, mostly 1% or less, and none at all have so far found any clinical significance. Obviously, they should not be used.

Unfortunately, busy medical professionals don’t have time to review the statistics and few of them are actually aware of the different ways the statistics can be manipulated.

Statin drugs do not work

The statin drugs are effective at around 1%. That is you have to treat 100 people to prevent one heart attack. This is not very effective, in fact it is ridiculously ineffective. Other than what I have been writing over the last year to verify this all need to do is go to the Pfizer (who make Lipitor) website and look for a table in a document titled “Product Information Lipitor” which presented the following table.


The table is duplicated here exactly as it appears on the Pfizer website. It is the research on taking 10 mg of Lipitor. It shows in the fourth column the “Absolute Risk Reduction” of between 0.06% and 1.9%, that is, very low real risk reduction. In the sixth column it shows the relative risk reduction of between 20% and 38%, which looks so much better but is really misleading. This is where the doctors get confused. They think it is the absolute risk reduction. The fifth column, “Number Needed to Treat Per Year,” is the most telling as it shows to have a single effect you need to treat between 176 and 555.2 people, depending on the outcome desired. That is a lot of people have to be taking this drug to stop one heart attack or possibly save a single life. Levels like this are not clinically significant and do not warrant taking this drug. To be clinically significant it needs to be an absolute risk of 25-30%, not 1 or 2%. I know it sounds a bit repetitive but you can get a much greater effect with only a small change in your diet.

Monday, February 8, 2010

Cholesterol: It’s Not the Killer

Since the advent of cholesterol lowering drugs cholesterol has become “public enemy number one” and has taken nearly all the blame for the increase in CVD. Unfortunately this has led to a lot of misinformation and misdirection in treating the real illness of CVD and its causes.
The current ideology is far from the truth and can be dangerous—particularly since the overwhelming current evidence points to CVD as a result of poor lifestyle and dietary choices that lead to inflammation. In reality, CVD is now recognized as a disease of low-grade chronic inflammation of the vascular lining and an inappropriate wound healing of blood vessels. There is now extensive and growing evidence that inflammation is central to all stages of this disease, from the initial lesion to end-stage thrombotic complications. CVD is not a disease of cholesterol or even cholesterol accumulation.

Cholesterol is associated with the risk of CVD but it is not the disease. The cholesterol levels measured at the doctor’s office and in most studies are blood cholesterol levels and are representative of liver function . Cholesterol is a symptom of an underlying health problem. It predicts less than 35% of cardiovascular disease. The only reason we try to get it down is because a drug company can make money selling drugs.

Along with other signalling molecules, insulin controls the packaging of cholesterol and triglycerides into LDL (low-density lipoproteins), VLDL (very low-density lipoproteins), HDL (high-density lipoproteins) and other lipoproteins. Glucagon (a hormone secreted by the pancreas) inhibits the enzyme and insulin activates the enzyme. To control cholesterol production, you want to increase glucagon and decrease insulin. That is, consume only low GI foods.
There is also strong evidence that stress increases a person’s inflammatory markers and cholesterol. One possibility may be that stress encourages the body to produce more energy in the form of metabolic fuels—fatty acids and glucose.

Cholesterol is good for you

Not only is cholesterol not the enemy, but also it is essential to good health and wellbeing. Every cell in the body needs cholesterol in its membrane, where cholesterol plays a critical role in cell communication. Without cholesterol, cell membranes are incomplete and, as a result, their functional role deteriorates. Cholesterol is also used in the mitochondria of the cell and plays a vital role in cell energy production—not to mention its essential role in the brain structure and function. Cholesterol is the starting material of many essential chemicals including vitamin D, steroid hormones and the bile acids necessary for digestion.

For major drug companies, convincing the public that lower cholesterol levels equal good health is a marketing scheme. The goal of these companies is not your good health; it’s their profits. This “marketing messaging” has gone too far, especially considering that recent studies show that cholesterol may have protective properties against cancer.

Cholesterol is the most abundant organic molecule in the brain which contains almost a quarter of the unesterified cholesterol present in the entire body. In 2001, in groundbreaking research and with media fanfare, cholesterol was identified as the synaptogenic factor that is responsible for the development of synapses, the connections in the brain. The glial cells of the central nervous system that perform the housekeeping functions in the brain produce their own cholesterol for the specific purpose of providing nerve cells with the vital component required for synapse function. Cholesterol is also required for the function of serotonin receptors in the brain. Serotonin is the chemical in our brain that makes us feel happy. Low cholesterol level has been associated with mortality due to suicides and accidental deaths.

A thirty-year study published in 1987 provides evidence that elevated cholesterol in people over the age of 50 does not increase the risk of heart attack. Cholesterol levels of people free of coronary heart disease (CHD) and cancer were measured; the study found that there was no increase in death rate in those with high cholesterol. Research on the effects of cholesterol levels and age shows that high cholesterol levels in people over the age of 75 are protective, not harmful. A separate study published in the European Heart Journal (1997) found that the risk of cardiac death was the same in groups of people with low or normal cholesterol levels as those with high cholesterol.

Maybe we need to rethink the billions of dollars we spend each year on drugs that lower cholesterol and spend the money on the real risk factors associated with cardiovascular disease: our lifestyles and choices, including nutritional and environmental factors that increase inflammation.

Stay tuned because there is more to come over the next weeks.

Monday, February 1, 2010

Give us your ideas

Drdingle.com is creating a new membership database that will be open and operational hopefully in April 2010. We are looking to all our wonderful current followers to help us develop this new tool.

We would like to know what you want more of from Dr Dingle? Topics you would like him to look into more, areas you need more help with or other ideas to improve your health and wellbeing. Just email your ideas to our program manager Rebecca via rebecca@drdingle.com or rebecca@peterdingle.com both of these will work.